Recent investigations have additionally identified an imbalance in the fibroblast growth factor 21 (FGF21) and MAPK1 signaling axes as key determinants of hepatic lipid metabolism disorders during ketosis. Here, FGF21 is linked to Disorder of lipid metabolism.